Chambers Rebecca — SEC insider filings
SEC reporting owner CIK 1823563. 44 insider filings on record with FilingPulse; latest filed 2026-09-04.
Transaction summary — filings shown
Covers all 44 filings on record, filed 2021-03-17 to 2026-09-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 20 legs across 14 filings — 136,766 shares, $6,258,447 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 53.
- Largest priced transaction: sale of 16,727 shares @ $50.72 ($848,373) in Outset Medical, Inc., filed 2021-06-25.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Outset Medical, Inc. (OM) | Chief Financial Officer | 6 | — | 6 legs · 66,908 sh · $3,385,038 | 11 |
| VERACYTE, INC. (VCYT) | Chief Financial Officer | 30 | — | 12 legs · 68,634 sh · $2,817,696 | 35 |
| Inari Medical, Inc. (NARI) | Director | 7 | — | 2 legs · 1,224 sh · $55,713 | 5 |
| Alamar Biosciences, Inc. (ALMR) | Director | 1 | — | — | 2 |
Insider filings — Chambers Rebecca
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-04 | 4 | VERACYTE, INC. (VCYT) | Tax withholding (F): 3,603 @ $44.88 · Sale (S): 2,477 @ $42.81 · Sale (S): 1,175 @ $43.71 | EDGAR |
| 2026-06-04 | 4 | VERACYTE, INC. (VCYT) | Tax withholding (F): 3,693 @ $47.80 · Sale (S): 1,600 @ $49.28 · Sale (S): 1,961 @ $50.09 | EDGAR |
| 2026-04-20 | 4 | Alamar Biosciences, Inc. (ALMR) | Other (J): 140,612 (derivative) @ $0 · Other (J): 140,612 (derivative) @ $0 | EDGAR |
| 2026-03-10 | 4 | VERACYTE, INC. (VCYT) | Grant/award (A): 36,181 @ $0 · Grant/award (A): 13,157 @ $0 | EDGAR |
| 2026-03-06 | 4 | VERACYTE, INC. (VCYT) | Sale (S): 4,400 @ $35.55 · Sale (S): 13,941 @ $36.33 | EDGAR |
| 2026-03-04 | 4 | VERACYTE, INC. (VCYT) | Tax withholding (F): 7,234 @ $36.01 | EDGAR |
| 2026-03-02 | 4 | VERACYTE, INC. (VCYT) | Grant/award (A): 59,324 @ $0 · Tax withholding (F): 12,049 @ $38.75 | EDGAR |
| 2025-12-04 | 4 | VERACYTE, INC. (VCYT) | Tax withholding (F): 3,384 @ $46.16 · Sale (S): 8,537 @ $46.61 · Sale (S): 4,741 @ $47.25 | EDGAR |
| 2025-11-07 | 4 | VERACYTE, INC. (VCYT) | Sale (S): 7,000 @ $41 | EDGAR |
| 2025-09-04 | 4 | VERACYTE, INC. (VCYT) | Tax withholding (F): 5,371 @ $30.11 | EDGAR |
| 2025-06-04 | 4 | VERACYTE, INC. (VCYT) | Tax withholding (F): 5,370 @ $26.74 | EDGAR |
| 2025-03-10 | 4 | VERACYTE, INC. (VCYT) | Grant/award (A): 30,200 @ $0 | EDGAR |
| 2025-03-03 | 4 | VERACYTE, INC. (VCYT) | Grant/award (A): 23,170 @ $0 · Tax withholding (F): 11,911 @ $33.84 · Tax withholding (F): 11,070 @ $34.76 | EDGAR |
| 2025-02-19 | 4 | Inari Medical, Inc. (NARI) | Code (U): 9,684 | EDGAR |
| 2025-02-05 | 4 | VERACYTE, INC. (VCYT) | Sale (S): 527 @ $43.85 | EDGAR |
| 2024-12-04 | 4 | VERACYTE, INC. (VCYT) | Tax withholding (F): 3,464 @ $44.12 · Sale (S): 7,000 @ $43.23 | EDGAR |
| 2024-11-14 | 4 | VERACYTE, INC. (VCYT) | Sale (S): 15,275 @ $38.34 | EDGAR |
| 2024-09-04 | 4 | VERACYTE, INC. (VCYT) | Tax withholding (F): 3,464 @ $31.55 | EDGAR |
| 2024-06-24 | 4 | Inari Medical, Inc. (NARI) | Sale (S): 260 @ $45.99 | EDGAR |
| 2024-06-04 | 4 | VERACYTE, INC. (VCYT) | Tax withholding (F): 3,462 @ $20.75 | EDGAR |
| 2024-05-21 | 4 | Inari Medical, Inc. (NARI) | Sale (S): 964 @ $45.39 | EDGAR |
| 2024-04-26 | 4 | Inari Medical, Inc. (NARI) | Grant/award (A): 4,126 @ $42.41 | EDGAR |
| 2024-03-19 | 4 | VERACYTE, INC. (VCYT) | Grant/award (A): 4,318 @ $0 · Tax withholding (F): 2,189 @ $21.10 | EDGAR |
| 2024-03-08 | 4 | VERACYTE, INC. (VCYT) | Grant/award (A): 59,856 @ $0 | EDGAR |
| 2024-03-05 | 4 | VERACYTE, INC. (VCYT) | Tax withholding (F): 6,112 @ $24 | EDGAR |
| 2023-12-05 | 4 | VERACYTE, INC. (VCYT) | Tax withholding (F): 1,800 @ $26.54 | EDGAR |
| 2023-09-06 | 4 | VERACYTE, INC. (VCYT) | Tax withholding (F): 3,652 @ $26.70 | EDGAR |
| 2023-06-06 | 4 | VERACYTE, INC. (VCYT) | Tax withholding (F): 1,183 @ $26.72 | EDGAR |
| 2023-05-19 | 4 | Inari Medical, Inc. (NARI) | Grant/award (A): 2,412 @ $0 | EDGAR |
| 2023-03-09 | 4 | VERACYTE, INC. (VCYT) | Grant/award (A): 26,014 @ $0 · Grant/award (A): 42,956 (derivative) @ $0 | EDGAR |
| 2023-03-03 | 4 | VERACYTE, INC. (VCYT) | Tax withholding (F): 2,726 @ $24.10 | EDGAR |
| 2022-12-06 | 4 | VERACYTE, INC. (VCYT) | Tax withholding (F): 735 @ $29.14 | EDGAR |
| 2022-09-07 | 4 | VERACYTE, INC. (VCYT) | Tax withholding (F): 3,023 @ $19.18 | EDGAR |
| 2022-08-09 | 4 | VERACYTE, INC. (VCYT) | Grant/award (A): 21,404 @ $0 · Grant/award (A): 36,496 (derivative) @ $0 | EDGAR |
| 2022-05-27 | 4 | Inari Medical, Inc. (NARI) | Grant/award (A): 2,420 @ $0 | EDGAR |
| 2022-03-07 | 4 | VERACYTE, INC. (VCYT) | Grant/award (A): 20,728 @ $0 · Grant/award (A): 37,773 (derivative) @ $0 | EDGAR |
| 2021-07-20 | 4 | VERACYTE, INC. (VCYT) | Grant/award (A): 34,000 @ $0 · Grant/award (A): 67,000 (derivative) @ $0 | EDGAR |
| 2021-06-25 | 4 | Outset Medical, Inc. (OM) | Option exercise (M): 16,727 @ $6.25 · Sale (S): 16,727 @ $50.72 · Option exercise (M): 16,727 (derivative) @ $0 | EDGAR |
| 2021-06-22 | 4 | Inari Medical, Inc. (NARI) | Grant/award (A): 1,950 @ $0 | EDGAR |
| 2021-05-26 | 4 | Outset Medical, Inc. (OM) | Option exercise (M): 16,727 @ $6.25 · Sale (S): 16,727 @ $45.11 · Option exercise (M): 16,727 (derivative) @ $0 | EDGAR |
| 2021-04-28 | 4 | Outset Medical, Inc. (OM) | Option exercise (M): 16,727 @ $6.25 · Sale (S): 8,499 @ $56.33 · Sale (S): 8,228 @ $56.89 · Option exercise (M): 16,727 (derivative) @ $0 | EDGAR |
| 2021-03-29 | 4 | Outset Medical, Inc. (OM) | Option exercise (M): 16,727 @ $6.25 · Sale (S): 3,592 @ $49.11 · Sale (S): 13,135 @ $50.16 · Option exercise (M): 16,727 (derivative) @ $0 | EDGAR |
| 2021-03-18 | 4/A | Outset Medical, Inc. (OM) | Grant/award (A): 27,037 (derivative) @ $0 | EDGAR |
| 2021-03-17 | 4 | Outset Medical, Inc. (OM) | Grant/award (A): 13,597 @ $0 · Grant/award (A): 27,037 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-03-15 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1823563 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs